Section of Nephrology and Endocrinology, Clinic of Internal Medicine, Sykehuset Telemark, Norway.
Nephrol Dial Transplant. 2010 May;25(5):1680-7. doi: 10.1093/ndt/gfp681. Epub 2009 Dec 27.
Kidney transplantation generally improves long-term survival in patients with end-stage renal disease. However, in patients older than 70 years of age, only limited data are available that directly compare the potential survival benefit of transplantation versus dialysis.
All patients aged above 70 years who started dialysis between 1990 and 2005 and were waitlisted for kidney transplantation were included in the study. They were categorized according to time periods of inclusion (1990-99 vs 2000-05). Survival rates of altogether 286 dialysis patients were analyzed with a Kaplan-Meier model, as well as with a time-dependent Cox model. Comparisons were made between those who received a transplant and those who did not, and further between the two time periods.
Median age at inclusion was 73.6 years (interquartile range 72.3-75.6). Two hundred and thirty-three patients (81%) received a kidney transplant during follow-up. Transplant recipients experienced an increased mortality in the first year after transplantation when compared to waitlisted patients. Patients starting dialysis between 1990 and 1999 had no significant long-term benefit of transplantation; HR for death 1.01 (0.58-1.75). In contrast, there was a substantial long-term benefit of transplantation among those starting dialysis after 2000; HR for death 0.40 (0.19-0.83), P = 0.014.
Survival after kidney transplantation in patients over 70 years has improved during the last decade and offers a survival advantage over dialysis treatment. Our experience supports the use of kidney transplantation in this age group if an increased early post-operative risk is accepted. This transplant policy may be challenged for priority reasons.
肾移植通常可提高终末期肾病患者的长期生存率。然而,在 70 岁以上的患者中,只有有限的数据直接比较移植与透析的潜在生存获益。
本研究纳入了 1990 年至 2005 年间开始透析且等待肾移植的所有 70 岁以上患者。根据纳入时间(1990-99 年与 2000-05 年)进行分组。采用 Kaplan-Meier 模型和时依 Cox 模型分析了总共 286 例透析患者的生存率。比较了接受移植和未接受移植的患者,以及两个时间段的患者。
中位纳入年龄为 73.6 岁(四分位间距 72.3-75.6)。233 例(81%)患者在随访期间接受了肾移植。与等待移植的患者相比,移植后第一年移植受者的死亡率增加。1990 年至 1999 年开始透析的患者没有明显的移植长期获益;死亡的 HR 为 1.01(0.58-1.75)。相比之下,2000 年后开始透析的患者接受移植具有显著的长期获益;死亡的 HR 为 0.40(0.19-0.83),P = 0.014。
70 岁以上患者的肾移植后生存率在过去十年中有所提高,并且与透析治疗相比具有生存优势。我们的经验支持在接受较高的术后早期风险的情况下在该年龄组中使用肾移植。由于优先权原因,这种移植策略可能会受到挑战。